Citations Report

Metabolomics:Open Access : Citations & Metrics Report

Articles published in Metabolomics:Open Access have been cited by esteemed scholars and scientists all around the world.

Metabolomics:Open Access has got h-index 14, which means every article in Metabolomics:Open Access has got 14 average citations.

Following are the list of articles that have cited the articles published in Metabolomics:Open Access.

	2024	2023	2022	2021	2020	2019	2018
Total published articles	20	15	20	30	24	7	9
Research, Review articles and Editorials	0	0	0	1	2	0	5
Research communications, Review communications, Editorial communications, Case reports and Commentary	20	15	20	29	22	7	4
Conference proceedings	0	0	8	2	2	45	48
Citations received as per Google Scholar, other indexing platforms and portals	959	691	102	110	105	105	96

Journal total citations count	895
Journal impact factor	1.8
Journal 5 years impact factor	3.73
Journal cite score	2.25
Journal h-index	14
Journal h-index since 2019	9

Important citations

Lu DY, Lu TR (2014) Innovations in Pharmaceuticals and Pharmacotherapy. IPP 2: 458-469. View at Publisher View at Google Scholar
Smith AJ, Oertle J, Warren D, Prato D (2016) Chimeric antigen receptor (CAR) T cell therapy for malignant cancers: Summary and perspective. Journal of Cellular Immunotherapy 2: 59-68. View at Publisher View at Google Scholar
Lu DY, Chen EH, Wu HY, Lu TR, Xu B,et al. (2017) Anticancer drug combinations, how far we can go through?. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)17: 21-8. View at Publisher View at Google Scholar
Lu DY, Lu TR, Ding J, Xu B, Che JY, et al. (2015) Anticancer drug sensitivity testing, a historical review and future perspectives. Current Drug Therapy 10: 44-55. View at Publisher View at Google Scholar
Lu DY, Lu TR, Xu B, Ding J (2015) Pharmacogenetics of cancer therapy: breakthroughs from beyond?. Future Science OA 1. View at Publisher View at Google Scholar
Lu DY, Lu TR, Chen XL, Chen EH, Ding J, et al. (2015)Cancer bioinformatics, its impacts on cancer therapy. Metabolomics 5: e133. View at Publisher View at Google Scholar
Lu DY, Lu TR, Wu HY (2014) Personalized cancer therapy, a perspective. Clin Exp Pharmacol 4:153. View at Publisher View at Google Scholar
Lu DY, Lu TR, Wu HY (2013) New insights into individualized antimetastatic therapy. Advanced Techniques in Biology & Medicine View at Publisher View at Google Scholar
Lu DY, Lu TR, Wu HY, Cao S (2013) Cancer Metastasis treatments. Current Drug Therapy 8: 24-29. View at Publisher View at Google Scholar
Ivanov DD, Melnik AA (2016) Pharmacogenetic testing in a nephrologic clinic. The kidneysPp: 12-16. View at Publisher View at Google Scholar
Cacabelos R, Torrellas C, LÃƒÂ³pez-MuÃƒÂ±oz F (2016) Pharmacogenomics of Antidepressant Drugs. InMelatonin, Neuroprotective Agents and Antidepressant Therapy Springer India Pp: 545-609. View at Publisher View at Google Scholar
Cacabelos R (2016) Epigenetics of Brain Disorders: The Paradigm of AlzheimerÃ¢â‚¬â„¢s Disease. J Alzheimers Dis Parkinsonism 6: 2161-0460. View at Publisher View at Google Scholar
Cacabelos R, Torrellas C, Teijido O, Carril JC (2016) Pharmacogenetic considerations in the treatment of Alzheimer's disease. Pharmacogenomics 17:1041-1074. View at Publisher View at Google Scholar
Cacabelos R, Torrellas C, Cacabelos P, Villanueva MJ, PiÃƒÂ±eiro S, at el. (2015) Pharmacogenetics of neurodegenerative disorders. InPreventive and Predictive Genetics: Towards Personalised Medicine Springer International Publishing pp: 173-240. View at Publisher View at Google Scholar
Torrellas C, Carril JC, Cacabelos R (2014) Benefits of Pharmacogenetics in the Management of Hypertension. Journal of Pharmacogenomics & Pharmacoproteomics 5: 1. View at Publisher View at Google Scholar
Cacabelos R (2015) Impact of genomic medicine on the future of Neuropsychopharmacology. J Neuropsychopharmacol Mental Health 1. View at Publisher View at Google Scholar
Cacabelos R, Goldgaber D, Roses AD, Vostrov A, Matsuki H (2015) Gene interactions in the Pharmacogenomics of AlzheimerÃ¢â‚¬â„¢s disease. Front Genet 1. View at Publisher View at Google Scholar
Cacabelos R, Torrellas C, Carrera I (2015) Opportunities in pharmacogenomics for the treatment of Alzheimer's disease. Future Neurology 10: 229-252. View at Publisher View at Google Scholar
Cacabelos R, Torrellas C (2015) Epigenetics of aging and AlzheimerÃ¢â‚¬â„¢s disease: Implications for pharmacogenomics and drug response. International journal of molecular sciences 16: 30483-30543. View at Publisher View at Google Scholar
Cacabelos R (2014) Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics. Drug development research 75: 348-365. View at Publisher View at Google Scholar
Prev 1 2 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 Next »

Journal Highlights

Google Scholar citation report

Citations: 895

Metabolomics:Open Access received 895 citations as per Google Scholar report

Metabolomics:Open Access peer review process verified at publons

Indexed In

CAS Source Index (CASSI)
Index Copernicus
Google Scholar
Open J Gate
Genamics JournalSeek
ResearchBible
Electronic Journals Library
RefSeek
Directory of Research Journal Indexing (DRJI)
Hamdard University
EBSCO A-Z
OCLC- WorldCat
Scholarsteer
SWB online catalog
Virtual Library of Biology (vifabio)
Publons
Geneva Foundation for Medical Education and Research
Euro Pub

Metabolomics:Open Access